Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
2,769
-136
-5% -$15.9K 0.06% 374
2026
Q1
$350K Sell
2,905
-344
-11% -$39.7K 0.07% 323
2025
Q4
$342K Sell
3,249
-1,566
-33% -$147K 0.07% 296
2025
Q3
$408K Sell
4,815
-4,551
-49% -$375K 0.09% 234
2025
Q2
$744K Sell
9,366
-54,349
-85% -$4.32M 0.14% 153
2025
Q1
$4.8M Buy
63,715
+49,137
+337% +$4.59M 0.27% 89
2024
Q4
$1.39M Buy
+14,578
New +$1.5M 0.37% 64

Other funds holding MRK

GWN Securities's MRK Position: Q2 2026 in Review

GWN Securities reduced its Merck (MRK) stake by 4.7% in Q2 2026, selling an estimated $15.9K and leaving 2,769 shares worth $356K. The position accounts for 0.06% of the portfolio, ranked #374.

GWN Securities first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.8M in Q1 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GWN Securities held 2,769 shares of Merck worth $356K as of Q2 2026.
  • GWN Securities sold 136 Merck shares in Q2 2026, an estimated $15.9K.
  • Merck made up 0.06% of GWN Securities's portfolio in Q2 2026, its #374 holding.
  • GWN Securities first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • GWN Securities's Merck position peaked at $4.8M in Q1 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.